CURADIGM - Trademark Details
Status: 700 - Registered
Serial Number
79244477
Registration Number
5796583
Word Mark
CURADIGM
Status
700 - Registered
Status Date
2019-07-09
Filing Date
2018-08-01
Registration Number
5796583
Registration Date
2019-07-09
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Published for Opposition Date
2019-04-23
Law Office Assigned Location Code
N30
Employee Name
BROWN, TRICIA LYNN
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Products for medical use especially for metabolic pathways, namely, enzyme substrates and enzyme inhibitors; products for medical use especially for the diagnosis and treatment of tumors, namely, diagnostic preparation for medical purposes for the diagnosis of tumors and therapeutic pharmaceutical preparations for medical purposes for the treatment of tumors and rare hepatic diseases; preparations for medical use especially for modifying the bioavailability of therapeutic agents, namely, lipidic and polymeric formulation for drug delivery in the nature of drug delivery agents in the form of nanoparticles, nanovesicles, particles, vesicles, dissolvable films, coatings for tablets and hydrogels that facilitate the delivery of pharmaceutical preparations; preparations for medical use especially for modifying liver functions, namely, pharmaceutical preparations for the treatment of liver diseases and disorders and pharmaceutical preparations to alter hepatic metabolization pathways; preparations for medical use for modifying the functions of the reticuloendothelial system, namely, pharmaceutical preparations for the treatment of reticuloendothelial system diseases and disorders and pharmaceutical preparations to alter reticuloendothelial system endocytosis pathways; preparations made with nanomaterials for the delivery of therapeutic agents, namely, drug delivery agents in the form of enterally, parenterally in the nature of intravenous, or topically administered nanomaterials that facilitate the delivery of pharmaceutical preparations; chemical reagents for medical use; bacteriological preparations for medical use; biological preparations for medical use for the treatment of cancer, central nervous system disorders, cardiological, immunological, gastrointestinal, metabolic and infection diseases; enzymes for medical use; enzyme preparations for medical use; chemical preparations for medical or pharmaceutical use, namely, for the treatment of cancer, central nervous system disorder, cardiological, immunological, gastrointestinal, metabolic and infection diseases; diagnostic products for medical use, namely, diagnostic preparations for medical purposes; drugs for medical use, namely, medical preparations for the treatment of cancer, central nervous system disorder, cardiological, immunological, gastrointestinal, metabolic and infectious diseases; medicines for human medicine, namely, medical preparations for the treatment of cancer, central nervous system disorder, cardiological, immunological, gastrointestinal, metabolic and infectious diseases; tonics medicines, namely, medical herbal preparations; antibiotics; antiseptics; chemico-pharmaceutical products for the treatment of the treatment of cancer, central nervous system disorder, cardiological, immunological, gastrointestinal, metabolic and infection diseases; pharmaceutical products, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; dietetic substances for medical use, namely, dietetic foods adapted for medical purposes; remedies for human medicine, namely, natural remedy preparations for the treatment of gastrointestinal conditions, hormonal and chemical imbalances, and sleep disorders
Goods and Services
Surgical and medical apparatus and instruments especially for the diagnosis and treatment of tumors; Surgical and medical apparatus and instruments especially for monitoring and modifying metabolic functions; Apparatus for modifying the functions of the reticuloendothelial system, namely, medical apparatus and instruments for use in endovascular and cardiovascular procedures; Apparatus for modulating liver functions, namely, medical apparatus and instruments for use in measuring, quantifying and assessing liver health and oxygenation and perfusion apparatus in the nature of perfusion pumps for liver transplantation; Apparatus for the delivery of therapeutic or diagnostic agents, namely, medical apparatus and units for dosage, measuring and monitoring, in the nature of drug delivery devices and systems, and organ oxygenation and perfusion apparatus in the nature of perfusion pumps; Apparatus for modulating hepatic blood flow, namely, organ perfusion apparatus in the nature of perfusion pumps; Testing apparatus for medical use in the nature of medical diagnostic apparatus for testing cancer calls, DNA, organ oxygenation and blood sugar levels; Diagnostic apparatus for medical use for testing cancer calls, DNA, organ oxygenation and blood sugar levels
Goods and Services
Scientific and technological services, namely, research and design especially in the field of nanomedicine, in the nature of nanotechnology applied to medicine; Biological research services; Bacteriological research services; Evaluations, estimates and research in scientific and technological fields provided by engineers and researchers, namely, conducting early evaluations in the field of new pharmaceuticals; Design and development of new products for third parties in the field of pharmaceutical preparations and diagnostic devices design; Technical research in the field of pharmaceutical project studies; Industrial analysis and research services, namely, biomedical research services; Chemical analysis; Chemical research; Chemistry services, namely, chemistry consultation; Surveying, namely, engineering work; Research and development of new products for others; Technical research in the field of pharmaceutical studies; Biological research, namely, radiobiology research, biological, pharmacokinetic, pharmacodynamic and immunological evaluation and toxicological evaluation; Medical research, namely, research in nanoscience and nanotechnology, especially applied to medicine
Goods and Services
Healthcare especially in the field of nanomedicine; medical services especially in the field of nanomedicine; hospital services; medical assistance; physiotherapy
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-11-07
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2018-11-07
Primary Code
010
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-11-07
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-11-07
Primary Code
044
Current Trademark Owners
Trademark Owner History
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
99 - Other (SAS).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
33
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
33
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
33
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Dreyfus & associƩs
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1431923
International Registration Date
2018-08-01
International Publication Date
2018-11-01
International Renewal Date
2028-08-01
Auto Protection Date
2020-05-01
International Status
001 - Request for extension of protection established
International Status Date
2018-11-01
Priority Claimed In
True
Priority Claimed Date
2018-03-06
First Refusal In
True
Trademark Events
Event Date | Event Description |
2018-11-01 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2018-11-07 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-11-13 | APPLICATION FILING RECEIPT MAILED |
2018-11-18 | ASSIGNED TO EXAMINER |
2018-11-18 | NON-FINAL ACTION WRITTEN |
2018-11-19 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2018-12-04 | REFUSAL PROCESSED BY MPU |
2018-12-04 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2018-12-21 | REFUSAL PROCESSED BY IB |
2019-02-03 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-02-07 | ASSIGNED TO LIE |
2019-02-08 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-02-08 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-03-01 | FINAL REFUSAL WRITTEN |
2019-03-04 | FINAL REFUSAL MAILED |
2019-03-07 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2019-03-07 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-03-08 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-03-14 | EXAMINERS AMENDMENT -WRITTEN |
2019-03-14 | EXAMINER'S AMENDMENT ENTERED |
2019-03-15 | EXAMINERS AMENDMENT MAILED |
2019-03-15 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-04-03 | NOTICE OF PUBLICATION |
2019-04-17 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2019-04-17 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2019-04-23 | PUBLISHED FOR OPPOSITION |
2019-05-03 | NOTIFICATION PROCESSED BY IB |
2019-07-09 | REGISTERED-PRINCIPAL REGISTER |
2019-10-09 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2019-10-29 | FINAL DISPOSITION PROCESSED |
2019-10-29 | FINAL DISPOSITION NOTICE SENT TO IB |
2019-11-15 | FINAL DECISION TRANSACTION PROCESSED BY IB |
2020-02-27 | CHANGE OF OWNER RECEIVED FROM IB |